within Pharmacolibrary.Drugs.ATC.J;

model J01DC05
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 2.1333333333333335e-05,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0073,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0026,
    k12             = 0.42,
    k21             = 0.42
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01DC05</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Cefotetan is a second-generation cephalosporin antibiotic used primarily in the treatment of infections caused by susceptible Gram-positive and Gram-negative bacteria, including urinary tract infections, intra-abdominal infections, and perioperative prophylaxis. It is administered parenterally and is approved for clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers, following a single intravenous dose administration.</p><h4>References</h4><ol><li><p>Liu, J, et al., &amp; Shentu, J (2020). Pharmacokinetics and Tolerability of Single and Multiple Intravenous Doses of Cefotetan Disodium in Healthy Chinese Volunteers. <i>Drug design, development and therapy</i> 14 613–620. DOI:<a href=&quot;https://doi.org/10.2147/DDDT.S234619&quot;>10.2147/DDDT.S234619</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32103903/&quot;>https://pubmed.ncbi.nlm.nih.gov/32103903</a></p></li><li><p>Shi, S, et al., &amp; Chen, H (2010). Pharmacokinetics and tolerability of intravenous cefotetan disodium for injection in healthy Chinese volunteers: A randomized, open-label, single- and multiple-dose study. <i>Clinical therapeutics</i> 32(10) 1832–1841. DOI:<a href=&quot;https://doi.org/10.1016/j.clinthera.2010.09.015&quot;>10.1016/j.clinthera.2010.09.015</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21194607/&quot;>https://pubmed.ncbi.nlm.nih.gov/21194607</a></p></li><li><p>Martin, C, et al., &amp; Albanese, J (1994). Clinical pharmacokinetics of cefotetan. <i>Clinical pharmacokinetics</i> 26(4) 248–258. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199426040-00002&quot;>10.2165/00003088-199426040-00002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8013159/&quot;>https://pubmed.ncbi.nlm.nih.gov/8013159</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01DC05;
